Merger

After a brush with delisting, Singapore's Orangekloud Technology has regained Nasdaq compliance, allowing it to focus on its AI-powered no-code platform.

A new report shows 91% of finance leaders are fixated on interest rates, while a massive AI readiness gap threatens to derail long-term transformation.

CrossCountry Consulting's major acquisition of CNM LLP signals a bold West Coast expansion and a move to dominate the Office of the CFO advisory market.

Once a failing firm, Aurelion Inc. bet its future on tokenized gold. The gamble paid off with a profitable quarter, but regulatory risks loom large.

After a strong Q4, Amprius launches a strategic roadshow to pitch its high-energy silicon anode batteries to investors and key aerospace and defense players.

As shadow AI and autonomous agents create huge risks, Teramind's new platform offers total visibility to help firms innovate without sacrificing security.

A new partnership turns existing conference rooms into high-quality TV studios, aiming to boost ROI, culture, and the quality of corporate events.

The trans-pacific merger between US BioTek and Australia's NutriPATH creates a major new force in functional medicine, promising expanded global access.

EcoVadis awards highlight a major shift: sustainability is no longer about compliance, but a core driver of performance, resilience, and long-term value.

Ag Growth International brings back its 23-year former CFO to the board, signaling a major push for operational excellence amid financial pressures.

Texans Credit Union merges with Las Colinas Federal Credit Union, adding 10,000 members and expanding its footprint in a competitive North Texas market.

As Middle East conflict roiled markets, 24/7 on-chain gold offered an immediate safe haven, challenging the dominance of traditional financial systems.

A new DLA contract with REalloys seeks to onshore Samarium and Gadolinium production, vital for defense, using a breakthrough zero-waste technology.

Norwegian Cruise Line reports strong 2025 earnings but a weak 2026 outlook, as its new CEO points to internal missteps and charts a course for recovery.

Shareholder approval paves the way for cancer therapy innovator VERAXA to go public, aiming to accelerate its next-gen antibody-drug conjugate pipeline.

A $4.4 million inventory write-down plunges the world's first private cord blood bank into the red, raising questions about its public banking model.

Healthpeak Properties is launching a new senior housing REIT, Janus Living. What does this strategic pivot mean for investors and the real estate market?

AMTD Digital reports explosive growth, but a closer look reveals a complex strategy involving media, SPACs, and a recent change in auditors.

A landmark donation accelerates NUNM's campus growth, promising a new integrative medicine center to meet the soaring demand for holistic healthcare.

JBT Marel's renovated Florida center combines advanced labs, VR, and regulatory authority to fast-track the future of food production for its partners.